Dates

Headlines

September 17, 2018

Biggest Losers Win Big at Regis

Over the past three years, Regis employees have collectively lost hundreds of pounds by participating in our Biggest Loser contests. This summer, we finished our fifth season. Four teams competed, and the winning team lost 5% of its initial body weight. The contest was started from an employee suggestion and […]
August 6, 2018

Privacy Policy Updated

In compliance with GDPR standards, Regis has updated its Privacy Policy. Our site now uses cookies, and thus the following has been added to our policy: Cookies A cookie is a small file placed on your computer or device when you visit a website.  We use cookies for various functions, including […]
August 1, 2018

Joe Miller, Vice President of Chemistry

Regis is proud to welcome Joe MIller, Ph.D. to the new senior leadership role of Vice President of Chemistry. Joe will align our core chemical development groups: Process Research, Process Development, and Analytical Method Development into one cohesive customer-focused team and deliver great solutions to our customers. Joe received his […]
July 23, 2018

Meet Nathan

Congratulations to Nathaniel Kuffel for his promotion to Quality Control Chem II. Nathan holds a Bachelor’s degree in analytical chemistry and Master’s of Science from DePaul University. He earned his Master’s in 2015 while simultaneously gaining industry experience as an intern and research assistant at Perkin Elmer. Shortly after graduating […]
June 22, 2018

Dr. Louis J. Glunz III & the Founding of Regis

Louis J. Glunz III, Ph.D., was born on June 23, 1930. He founded Regis in 1956 and remains our Chairman today. Regis is a family-owned and operated business, a Glunz tradition since 1888. Dr. Glunz and his father would experiment together in a laboratory on the building’s third floor that […]
November 22, 2016

Regis Technologies Honored as Family Business of the Year

The Family Business Center at Loyola University Chicago’s Quinlan School of Business recently named Regis Technologies, Inc., the winner of the 2016 Illinois Family Business of the Year Award in the medium category (50-250 employees). Regis Technologies is a privately owned family-run business that has become a world-class leader in […]
August 4, 2015

Potent Compound Suite Now Open for Small Molecule Oncologicals

Regis Technologies is announcing their entry into the oncology market with the start up of the new Potent Compound Suite (PCS). The PCS allows Regis, a Chicago-based contract manufacturing organization (CMO), to target small molecule oncologicals and linker payload projects for antibody drug conjugates. Regis is a CMO operating a […]
May 8, 2015

Containment Performance Verification of the Potent Compound Suite Using Surrogate Monitoring

As part of commissioning of the Regis’ Potent Compound Suite 1 (PCS1), an industrial hygiene monitoring was performed by Safebridge Consultants, Inc., on March 4 and 5 of 2015 with the purpose to evaluate the containment performance of the facility. Based on the occupational exposure limits (OELs) of the future […]
March 6, 2015

Surrogate Powder Testing on Potent Compound Suite 1

With almost two years of planning and construction complete, Regis Technologies’ Potent Compound Suite 1 (PCS1) is in testing. On March 4th and 5th, an expert independent lab, Safebridge Consultants, Inc., performed a surrogate powder study on PCS1, in order to evaluate the containment capability of the suite and to […]
February 26, 2015

Regis Looks to Extend cGMP Services to the Oncology Market

Regis Technologies announced new potent compound capabilities this month for the development of oncology drug substances. Regis Technologies is proud to announce the commissioning and start up of their new Potent Compound Suite (PCS) for 2015. Regis is a contract manufacturing organization operating a 36,000 square foot, cGMP facility in […]
October 8, 2014

Potent Compound Initiative Underway

Regis’ Potent Compound Initiative is proceeding along well. Our Analytical Team underwent training last week on how to handle potent compounds with OEL’s (occupational exposure limit) down to 0.05 micrograms/m3 safely in the analytical labs. The Potent Compound Suite is expected to be commissioned at the end of the year, […]
January 21, 2014

Regis Technologies Reports Successful FDA Audit with no Form 483 Observations

—Two Most Recent FDA Audits had no Form 483’s, Highlighting Consistency of Regis’ Quality and Regulatory Excellence— —FDA Has Recognized Regis as a Control Testing Lab, Easing Inspection Requirements for Customers— —Visit Booth #1246 at InformEx to Learn More about Regis’ Quality Services— Morton Grove, IL, January 21, 2014 – […]